Skip to main content
. 2018 Jan 4;9(7):7522–7533. doi: 10.18632/oncotarget.23943

Figure 2. Representative images for three CTC types captured from peripheral blood of patients with suspicious abdominal masses.

Figure 2

(A) Top row: A cells with DAPI+/E&M+/CD45-/HE4+; middle row: B cells with DAPI+/E&M-/CD45-/HE4+ and bottom row: C cells with DAPI+/E&M+/CD45-/HE4-. (B) The number of A cells with DAPI+/E&M+/CD45-/HE4+ was higher in the ovarian cancer group than the benign (p = 0.016) and “other malignant” groups (p = 0.047). (C) The number of A + B cells with DAPI+/CD45-/HE4+ was higher in the ovarian cancer group than the benign (p = 0.020) and “other malignant” groups (p = 0.036).